Meeting Register Page

Meeting banner
LESI Life Sciences Committee "The current landscape in ATMP – IP, partnering, funding and more!"
This webinar intends to discuss the current market in the advanced therapeutic medicinal product (ATMP) space, with a particular focus on the challenges specific to this sector, and how those impact on aspects such as due diligence, collaboration, funding and deals.

These topics will be explored using case studies from two ATMP companies at different growth stages, Quell Therapeutics and NK:IO. Additional insights on access to technology, and issues on manufacturing and supply chain being provided by our speaker from the Cell and Gene Therapy Catapult, which works to support companies in this sector.

Matthew Garner - Head of IP, Cell and Gene Therapy Catapult
Jodie Albutt - VP of IP, Quell Therapeutics
Michael Hunt - CEO of NK:IO
Kerstin Papenfuss - Director, Pharma, Deep Science Ventures
Anna Gregson - Partner, Mathys & Squire LLP
* Required information